Načítá se...
Bayesian optimization for estimating the maximum tolerated dose in Phase I clinical trials
We introduce a Bayesian optimization method for estimating the maximum tolerated dose in this article. A number of parametric model-based methods have been proposed to estimate the maximum tolerated dose; however, parametric model-based methods need an assumption that dose–toxicity relationships fol...
Uloženo v:
| Vydáno v: | Contemp Clin Trials Commun |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7910500/ https://ncbi.nlm.nih.gov/pubmed/33681528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2021.100753 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|